Agreement Preliminary Statement Sample Clauses
Agreement Preliminary Statement. Alcon Swiss Preliminary Statement Alcon Vision Preliminary Statement Allocation Schedule Section 1.2(c) AMPPLIFY® Drug Delivery Technology Section 9.1 Annual Net Sales Section 1.6(a) Anti-Corruption Laws Section 9.1 Antitrust Laws Section 9.1 Antitrust Order Section 9.1 Assigned Contracts Section 1.1(a)(i)(C) Assumed Liabilities Section 1.1(c) Audited Financial Statements Section 9.1 Auditor Section 1.6(c)(ii) ▇▇▇▇ of Sale and Assumption Agreement Section 1.3(b)(iii) Books and Records Section 1.1(a)(i)(E) Business Introduction Business Benefit Plans Section 9.1 Business Day Section 9.1 Business IP Section 9.1 Business Material Adverse Effect Section 9.1
Agreement Preliminary Statement. Assigned Contracts 1.1(a)(ii) Assigned Domain Name Registrations 1.1(a)(iv) Assigned Patents 1.1(a)(iv) Assumed Liabilities 1.4(a) Bankruptcy Exception 2.2 Business Introduction Buyer Preliminary Statement Buyer/QAC Agreement 6.8 Closing 1.1(a) Closing Cash Amount 1.3(a) Closing Date 1.6 COBRA Rights 4.3(c) Company Plans 2.5(a) Consumed Inventory 1.3(b)(i) Encumbrances 1.1(a) ERISA 2.5(a) Exchange Act 5.6(b) Excluded Assets 1.1(b) Financial Statements 5.12 Indemnified Party 8.3 Indemnifying Party 8.3 Inventory 1.1(a)(i) Inventory Accounting 1.3(b)(i) Inventory Cap 1.3(a)(iii) KEE 5.6(a) KEE Agreement 5.6(a) Patent License Agreement 1.1(a)(iv) Licensed Intellectual Property 1.1(a)(iv) Losses 8.1 Payment and Accounting Date 1.3(b)(i) Permits 1.1(a)(vi) Permitted Encumbrances 2.3 Purchased Assets 1.1(a) Purchase Price 1.3(a) QAC 6.8 QAC Agreement 6.8 Retained Liabilities 1.4(b) Seller Preliminary Statement Seller’s Cost of Consumed Inventory 1.3(b)(i) Tangible Assets 1.1(a)(iii) Taxes 1.4(b)(ii) Threshold Amount 8.6(b)